A detailed history of Montag A & Associates Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Montag A & Associates Inc holds 74,035 shares of ABBV stock, worth $13 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares
74,035
Previous 71,265 3.89%
Holding current value
$13 Million
Previous $12.2 Million 19.61%
% of portfolio
0.7%
Previous 0.62%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$163.84 - $199.33 $453,836 - $552,144
2,770 Added 3.89%
74,035 $14.6 Million
Q2 2024

Jul 31, 2024

SELL
$154.79 - $180.76 $21,051 - $24,583
-136 Reduced 0.19%
71,265 $12.2 Million
Q1 2024

May 07, 2024

BUY
$159.82 - $182.1 $589,735 - $671,949
3,690 Added 5.45%
71,401 $13 Million
Q4 2023

Feb 07, 2024

SELL
$137.6 - $154.97 $29,308 - $33,008
-213 Reduced 0.31%
67,711 $10.5 Million
Q3 2023

Nov 09, 2023

SELL
$133.59 - $154.65 $8,148 - $9,433
-61 Reduced 0.09%
67,924 $10.1 Million
Q2 2023

Aug 09, 2023

BUY
$132.51 - $164.9 $8,878 - $11,048
67 Added 0.1%
67,985 $9.16 Million
Q1 2023

May 11, 2023

SELL
$144.61 - $166.54 $96,165 - $110,749
-665 Reduced 0.97%
67,918 $10.8 Million
Q4 2022

Feb 02, 2023

BUY
$138.31 - $165.87 $64,590 - $77,461
467 Added 0.69%
68,583 $11.1 Million
Q3 2022

Nov 09, 2022

BUY
$134.21 - $153.93 $373,103 - $427,925
2,780 Added 4.25%
68,116 $9.14 Million
Q2 2022

Aug 10, 2022

SELL
$137.62 - $174.96 $302,626 - $384,737
-2,199 Reduced 3.26%
65,336 $10 Million
Q1 2022

May 02, 2022

BUY
$131.98 - $163.75 $14,517 - $18,012
110 Added 0.16%
67,535 $10.9 Million
Q4 2021

Feb 09, 2022

SELL
$107.43 - $135.93 $174,681 - $221,022
-1,626 Reduced 2.35%
67,425 $9.13 Million
Q3 2021

Nov 08, 2021

SELL
$106.4 - $120.78 $74,480 - $84,546
-700 Reduced 1.0%
69,051 $7.45 Million
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $187,413 - $206,319
-1,832 Reduced 2.56%
69,751 $7.55 Million
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $5.27 Million - $7.11 Million
-65,466 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $108,418 - $127,247
1,262 Added 1.97%
65,466 $5.73 Million
Q2 2020

Aug 04, 2020

BUY
$73.37 - $98.18 $22,524 - $30,141
307 Added 0.48%
64,204 $6.3 Million
Q1 2020

May 06, 2020

BUY
$64.5 - $97.79 $59,340 - $89,966
920 Added 1.46%
63,897 $4.87 Million
Q4 2019

Feb 05, 2020

SELL
$72.13 - $90.25 $619,596 - $775,247
-8,590 Reduced 12.0%
62,977 $5.58 Million
Q2 2019

Aug 06, 2019

BUY
$65.7 - $83.98 $61,429 - $78,521
935 Added 1.32%
71,567 $5.2 Million
Q1 2019

May 01, 2019

SELL
$77.14 - $90.79 $15,428 - $18,158
-200 Reduced 0.28%
70,632 $5.69 Million
Q4 2018

Feb 06, 2019

BUY
$77.85 - $96.01 $39,392 - $48,581
506 Added 0.72%
70,832 $6.53 Million
Q3 2018

Nov 07, 2018

BUY
$88.91 - $98.84 $56,457 - $62,763
635 Added 0.91%
70,326 $6.65 Million
Q2 2018

Aug 01, 2018

SELL
$89.78 - $106.23 $83,854 - $99,218
-934 Reduced 1.32%
69,691 $6.46 Million
Q1 2018

May 07, 2018

BUY
$92.01 - $123.21 $94,402 - $126,413
1,026 Added 1.47%
70,625 $6.69 Million
Q4 2017

Feb 09, 2018

SELL
$89.56 - $98.21 $19,344 - $21,213
-216 Reduced 0.31%
69,599 $6.73 Million
Q3 2017

Nov 06, 2017

BUY
$69.85 - $89.22 $4.88 Million - $6.23 Million
69,815
69,815 $6.2 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $311B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Montag A & Associates Inc Portfolio

Follow Montag A & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Montag A & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Montag A & Associates Inc with notifications on news.